HCMT
SRPT icon

Highland Capital Management (Tennessee)’s Sarepta Therapeutics SRPT Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,153
Closed -$1M – 455
2026
Q1 		$1M Buy
+46,153
New +$893K 0.05% 237
2020
Q4 		– Sell
-12,542
Closed -$1.76M – 350
2020
Q3 		$1.76M Buy
12,542
+334
+3% +$50.8K 0.13% 175
2020
Q2 		$1.96M Buy
+12,208
New +$1.66M 0.15% 150

Other funds holding SRPT

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Highland Capital Management (Tennessee)'s SRPT Position: Q2 2026 in Review

Highland Capital Management (Tennessee) sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 46,153 shares — an estimated $1M sold.

Highland Capital Management (Tennessee) first reported a position in SRPT in Q2 2020 and held it in 3 quarters. The position peaked at $1.96M in Q2 2020. 89 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Highland Capital Management (Tennessee) reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 46,153 Sarepta Therapeutics shares in Q2 2026, an estimated $1M.
  • Highland Capital Management (Tennessee) first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 3 quarters.
  • Highland Capital Management (Tennessee)'s Sarepta Therapeutics position peaked at $1.96M in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.